WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Week 8_Part 2_Asthma Diagnosis and Treatment, Tests review Pulmonary function test results, Theraputic Considerations anti-inflammatory steroid Hydrocortisone 100mg/2mL, Hydrocortisone upregulates Beta-2 adrenergic receptors (Gs), 4 Stages stage 3 Sign of respiratory distress, Acute or Chronic Asthma Attack physiology Glucocorticoid Receptors, Acute or Chronic Asthma Attack clinical presentation Hyperventilation Rapid, Shallow Breaths Disorientation Hyperreflexia Muscle Weakness, Acute or Chronic Asthma Attack physiology Expected Arterial Blood Gas (ABG), Hydrocortisone decreases airway inflammation and mucus secretion, Hydrocortisone 100mg/2mL dose 50mg/kg every 4 hours for a pateint weighing 120 lbs Inject 54.4 mL every 4 hours, Beta-2 adrenergic receptors (Gs) beta-2 agonist Terbutaline, Albuterol causes Bronchodilation, Theraputic Considerations anticholinergic bronchodilator Ipratropium Bromide inhalation solution 0.5mg/2.5mL, Theraputic Considerations short acting beta 2 agonist Albuterol Inhalation solution, 0.5%, Beta-2 adrenergic receptors (Gs) beta-2 agonist Albuterol, Terbutaline 1mg/mL (IV) dose 0.1mg/kg/minute continuous infusion IV concentration of 0.1mg/mL For a patient weighing 120 lbs Inject 3,270 mL/hr, M3 M3 antagonist Ipratropium, Albuterol onset 1 minute to notice effects, Acute or Chronic Asthma Attack physiology Bronchial Muscle Constriction Airway Inflammation Airway Swelling Mucus Production Decrease Blood Pressure Vasodilation, 4 Stages stage 1 Hyperventilation with normal PO2 levels, Theraputic Considerations beta adrenergic receptor agonist Terbutaline 1mg/mL (IV)